Implementing Geriatric Assessment for Dose Optimization of Cyclin-dependent Kinase (CDK) 4/​6-inhibitors in Older Breast Cancer Patients

Principal Investigator: Peeter Karihtala
HUS Comprehensive Cancer Center

Link to the Clinical Trials.gov website